Attention Investors
Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000.    |   Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors."     |    KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."     |    ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
 ««+1  ««-1
 
 
SMS Pharmaceuticals LtdIndustry : Pharmaceuticals - Indian - Bulk Drugs
BSE Code:532815NSE Symbol: SMSPHARMAP/E(TTM):37.87
ISIN Demat:INE812G01025Div & Yield %:0.13EPS(TTM):7.5
Book Value(Rs):76.9545202Market Cap ( Cr.):2659.72Face Value(Rs):1
    Change Company 
( In Cr)
 Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
INCOME :      
Sales Turnover 835.55752.35554.56555.34611.60453.32
Excise Duty52.8043.0832.5135.4748.4341.37
Net Sales782.75709.27522.05519.87563.17411.95
Other Income 6.224.464.915.203.455.11
Stock Adjustments 64.811.00-36.08112.50-26.7313.14
Total Income853.78714.73490.88637.57539.89430.20
EXPENDITURE :      
Raw Materials 500.90425.04299.52387.80313.27259.50
Power & Fuel Cost56.7647.1235.9732.5823.3118.99
Employee Cost 69.7256.7850.0851.0241.1739.35
Other Manufacturing Expenses 29.8526.5217.8622.6316.1914.86
Selling and Administration Expenses 47.6835.6825.2821.1219.0210.18
Miscellaneous Expenses 2.692.142.512.462.342.18
Less: Pre-operative Expenses Capitalised0.000.000.000.000.000.00
Total Expenditure707.59593.28431.23517.61415.31345.06
Operating Profit146.20121.4559.65119.97124.5985.14
Interest 18.5423.6021.9719.1611.1912.32
Gross Profit127.6697.8537.68100.81113.4072.82
Depreciation34.3431.5232.1332.1522.2822.07
Profit Before Tax93.3266.335.5568.6691.1250.75
Tax19.6415.130.0014.9216.058.94
Fringe Benefit tax0.000.000.000.000.000.00
Deferred Tax5.301.781.47-14.3014.119.13
Reported Net Profit68.3849.424.0868.0460.9632.69
Extraordinary Items 0.010.03-0.040.00-0.01-0.03
Adjusted Net Profit68.3749.394.1268.0460.9732.72
Adjst. below Net Profit -0.51-0.07-0.210.04-0.16-0.09
P & L Balance brought forward359.04322.22320.88265.35214.55197.05
Statutory Appropriations 0.000.000.000.000.000.00
Appropriations 13.3912.542.5412.5410.0015.10
P & L Balance carried down413.52359.04322.22320.88265.35214.55
Dividend0.000.000.000.000.000.00
Preference Dividend0.000.000.000.000.000.00
Equity Dividend %40.0040.0030.0030.0030.0025.00
Earnings Per Share-Unit Curr7.715.840.488.047.203.86
Earnings Per Share(Adj)-Unit Curr7.715.840.488.047.203.86
Book Value-Unit Curr74.1364.0258.4958.3350.5943.40